Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill, invasively mechanically ventilated COVID-19 patients.
Saved in:
| Title: | Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill, invasively mechanically ventilated COVID-19 patients. |
|---|---|
| Authors: | Lim, Endry H. T.1,2 (AUTHOR) e.lim@amsterdamumc.nl, Vlaar, Alexander P. J.1 (AUTHOR), de Bruin, Sanne1 (AUTHOR), Rückinger, Simon3 (AUTHOR), Thielert, Claus4 (AUTHOR), Habel, Maria5 (AUTHOR), Guo, Renfeng6 (AUTHOR), Burnett, Bruce P.6 (AUTHOR), Dickinson, James4 (AUTHOR), Brouwer, Matthijs C.2 (AUTHOR), Riedemann, Niels C.5 (AUTHOR), van de Beek, Diederik2 (AUTHOR), Witzenrath, Martin (AUTHOR), van Paassen, Pieter (AUTHOR), Heunks, Leo M. A. (AUTHOR), Mourvillier, Bruno (AUTHOR), Tuinman, Pieter R. (AUTHOR), Saraiva, José Francisco K. (AUTHOR), Marx, Gernot (AUTHOR), Lobo, Suzana M. (AUTHOR) |
| Source: | Intensive Care Medicine Experimental. 6/19/2023, Vol. 11 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2197425X |
|---|---|
| DOI: | 10.1186/s40635-023-00520-8 |
